Status:
UNKNOWN
Renin-Angiotensin System Inhibitors and COVID-19
Lead Sponsor:
Societa Italiana dell'Ipertensione Arteriosa
Conditions:
COVID-19
Hypertension
Eligibility:
All Genders
18-120 years
Brief Summary
Multicentric non-profit observational study, in patients with COVID-19 hospitalized in Italy, conducted through a pseudonymised survey.
Detailed Description
The recent SARS-CoV-2 Coronavirus pandemic and subsequent spread of the disease called COVID-19 brought back to the discussion a topic already highlighted during the SARS-CoV-4 crown-related SARS epid...
Eligibility Criteria
Inclusion
- Patients affected by COVID19 referring to italian outpatient clinics or hospitals
Exclusion
- \-
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04331574
Start Date
March 10 2020
End Date
April 30 2020
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spedali Civili di Brescia
Brescia, Italy